Docetaxel and zoledronic acid combination administered in two different sequences in hormone refractory prostate cancer patients: Phase I clinical study – ZANTE

✍ Scribed by G. Facchini; M. Caraglia; A. Morabito; S.G. Bruni; G. Nasti; P. Maiolino; S. Striano; A. Budillon; A. Di Napoli; M. Marra; C. Pisano; S. Pignata; F. Perrone; R.V. Iaffaioli

• Book ID: 119233675
• Publisher: Elsevier Science
• Year: 2008
• Tongue: English
• Weight: 38 KB
• Volume: 6
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/j.ejcsup.2008.06.048